Ankylosing spondylitis (AS) can involve the eye, gastrointestinal system, cardiopulmonary system, skin, kidneys, and spinal and peripheral joints. It is rarely accompanied by immunoglobulin A (IgA) nephropathy. Although IgA is involved in both AS and IgA nephropathy, the relationship between these diseases remains unclear. We detected hematuria and proteinuria in a 32-year-old male patient with ankylosing spondylitis that remained stable for 4 years through treatment with etanercept, a tumor necrosis factor-α (TNF-α) inhibitor, and diagnosed IgA nephropathy through a renal biopsy. IgA nephropathy seems to be less commonly associated with AS disease activity or specific treatment such as TNF-α inhibitor use.
Ankylosing spondylitis (AS), a type of spondyloarthritis, is a chronic inflammatory disorder that usually involves the spinal and peripheral joints. Uveitis is the most common extra-articular manifestation; other manifestations affect the gastrointestinal system, cardiopulmonary system, skin, and kidneys. thus, these diseases are considered to be closely related. 3 However, as some studies have suggested that the prevalence rates of IgA nephropathy in healthy individuals and patients with AS do not vary significantly, the pathophysiological and epidemiological relationship is unclear. 4 Here we report a case in which IgA nephropathy developed in a patient with AS whose overall disease activity was well controlled with etanercept, a TNF-α inhibitor. There were no other abnormal findings.
A peripheral blood smear revealed a white blood 
DISCUSSION
Although kidney involvement is uncommon in AS, it can be caused by concurrent conditions such immune-fixation EP. Therefore, the role of IgA is assumed to be small. TNF-α is known to induce glomerular inflammation and increase glomerular permeability. 9 Thus, TNF-α inhibitors are assumed to theoretically reduce proteinuria in nephropathy; however, there is no strong basis for this belief. The reported cases of IgA nephropathy in patients with AS using TNF-α inhibitors are summarized in Table 1 . Özçakar et al. 11 Lee et al. 1 Lee et al. 
